Steps forward for cancer precision medicine

Salgado, Roberto; Moore, Helen; Martens, John; Lively, Tracy; Malik, Shakun; McDermott, Ultan; Michiels, Stefan; Moscow, Jeffrey A.; Tejpar, Sabine; McKee, Tawnya; Lacombe, Denis

doi:10.1038/nrd.2017.218

R. Salgado (Roberto), H.M. Moore (Helen), J.W.M. Martens (John), T. Lively (Tracy), S. Malik (Shakun), U. McDermott (Ultan), S. Michiels (Stefan), Moscow, J.A. (Jeffrey A.), S. Tejpar (Sabine), McKee, T. (Tawnya), et al. D. Lacombe (Denis)

2018

Steps forward for cancer precision medicine

Nature Reviews Drug Discovery , Volume 17 - Issue 1 p. 1- 2

The availability of targeted anticancer drugs and the relative affordability of genomic analyses has led to a growing expectation among patients with cancer that they can receive personalized treatment based on the genomic signature of their tumour. Here, we discuss some of the challenges and steps needed to bring such approaches into routine practice.

Additional Metadata
Persistent URL	doi.org/10.1038/nrd.2017.218, hdl.handle.net/1765/103840
Journal	Nature Reviews Drug Discovery
Rights	no subscription
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Salgado, R., Moore, H., Martens, J., Lively, T., Malik, S., McDermott, U., … Lacombe, D. (2018). Steps forward for cancer precision medicine. Nature Reviews Drug Discovery (Vol. 17, pp. 1–2). doi:10.1038/nrd.2017.218

Steps forward for cancer precision medicine

Publication

Publication

About

Steps forward for cancer precision medicine

Publication

Publication

Workflow

Workflow

Add Content